Only logged-in users can see full content details
RIJEKA, March 24
(Hina) - The Rijeka-based Jadran Galenski
Laboratorij (JGL) on Tuesday confirmed that it had withdrawn its
binding bid for a majority stake in the Zagreb-headquartered Institute
of Immunology (IMZ), citing that too short periods for implementation
of tasks as envisaged in the proposed plan for prospective investors.